2026 Regular Session

HB 920

INSURANCE/HEALTH: Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note)

In Committee

Jurisdiction

Louisiana

Session

2026 Regular Session

Official source

Chamber

lower

Session

2026 Regular Session

Jurisdiction

Louisiana

Positions across the state

No public positions recorded for this legislation.

Arguments in favor

Reasons to support this legislation.

No arguments in favor have been submitted.

Submit yours

Arguments opposed

Reasons to oppose this legislation.

No arguments opposed have been submitted.

Submit yours

Legislative history

02/27House

First appeared in the Interim Calendar on 2/27/2026.

02/27House

Under the rules, provisionally referred to the Committee on Insurance.

02/27House

Prefiled.

03/09House

Read by title, under the rules, referred to the Committee on Insurance.

No geographic vote map is available for this bill from current records.

Floor votes and chamber actions

Recorded roll calls list how each member voted. Unanimous consent or voice vote appears in the official action history without a roll call; no member-level tally is available for those steps.

Recorded roll calls

Read the latest version inline or switch to a previous version.

HB 920

Sponsors

Primary sponsor

Positions across the state

Arguments in favor

Arguments opposed

Floor votes and chamber actions

Recorded roll calls

Bill text

Positions across the state

Floor votes and chamber actions

Recorded roll calls